OXIS INTERNATIONAL, INC. ANNUAL REPORT 2012

Company

GT Biopharma, Inc.

Filed

November 18, 2014

Period of Report

December 31, 2012

Accession Number

0001513160-14-000064

A 10-K is a company's comprehensive annual report, required by the SEC. It includes audited financial statements, a description of the business, risk factors, and management's discussion of results. Learn more about 10-K filings →